New T cell mechanism could lead to longer-lasting vaccines
Researchers at the University of Wisconsin School of Veterinary Medicine have identified a possible way to make longer…
Triassic Coelacanths May Have Heard the Ocean with Their Lungs
An analysis of two 240-million-year-old coelacanth fossils suggests a bizarre sensory adaptation: an ossified lung that transmitted sound…
How to look after your lungs this spring – The Irish News
As the seasons begin to change, many people have welcomed the clear blue skies and blooming flowers. However,…
Nasal Spray Could Protect Against Range of Respiratory Bugs
Scientists are testing a nasal spray that aims to put lungs on alert against just about any…
AI tool could help identify life-threatening transplant complications
A powerful artificial intelligence (AI) tool could give clinicians a head start in identifying life-threatening complications after stem…
RNA micelles enable targeted chemotherapy without immune toxicity
A new study in mice hints at the potential to use tiny particles made with RNA molecules to…
Artificial lung keeps patient alive after lung removal
By replacing both breathing and circulatory buffering, a novel artificial lung bought critical time after lung removal, revealed…
Study finds no safety or efficacy gap between paracetamol and ibuprofen for neonatal PDA
A small but rigorous randomized trial suggests paracetamol may be a feasible alternative to ibuprofen for late PDA…
Interferon response key to fighting rhinovirus infections in nasal passages
When a rhinovirus, the most frequent cause of the common cold, infects the lining of our nasal passages,…
Genetic differences in surfactant proteins influence retinopathy of prematurity risk
A new study from the University of Oklahoma suggests that small genetic differences in two proteins – previously…
Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis
Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve…
Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancer
Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows…